Having been the rival of U.S. economically, a paper published by IISS Peking University, summing up that, China is the loser. Comparing two titans’ prowess both economically and technologically, China is lacking too much. Compared to U.S., China is left behind numbers of areas such as core computing system, semiconductors, operating systems, and aerospace.
In 2025, China sets goals to be more self-reliant in economic policy and technology. The goal’s deadline to attain the project will arrive soon. With this the government is ready to pour billions for the goal. The government also combines public and private research with spending total as much as 2.8trn yuan. The ongoing project does not only cover spending and research, China closely watches Western military support to Ukraine to detect Western’s vulnerabilities.
SMIC, China’s biggest chipmaker plans to invest $5bn in 2022 for new semiconductors companies. Hong Kong unit of Standard Chartered, a British bank follows. It becomes the first foreign lender outside China. The goal’s deadlines are approaching, China’s dependence over Western however remains as the biggest concern.
Ying Bo, owner of Abogen Biosciences has worked with People’s Liberation Army, investing at least $2.3bn to develop local vaccines. They are launching ARCoVax, vaccine that will compete Western version. It was fast made, but there is no further information about massive production. 200m doses are far from 4bn doses for this year’s goal.
Another fear lies in foreign genetic-modification over China. China is anticipating that these foreign firms will take control over China’s grain supply. Thus, China develops its own local home-grown alternative. Dabeinong Biothechnology pours huge sum for research. But domestic production remains low. It means that China still relies on import of crops. Government fears continue, it is still looking the way out to be totally self-reliance.